Rukmono Siswishanto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rukmono Siswishanto has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aulia Ichlasul Rezza
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
2 shared publications - Dean Batrisha
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
2 shared publications - Detty Siti Nurdiati
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications - Irwan Endrayanto
Applied Mathematics Research Group, Department of Mathematics, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications - Dian Riski Ariesta
Gadjah Mada University
1 shared publication - Himawan Sartono
Gadjah Mada University
1 shared publication
Latest Publications
- Open Access
- 11 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 538
Clinical Evidence of Wearable-Derived Heart Rate Variability for Detecting Systemic Inflammation: A Systematic Review
Background/Objectives: Wearable devices capable of capturing heart rate variability (HRV) enable continuous assessment of autonomic nervous system function in real-world settings. Because systemic inflammation disrupts autonomic balance through vagal withdrawal and sympathetic activation, HRV has been proposed as a non-invasive digital biomarker of inflammatory activity. Despite the rapid expansion of wearable sensor technologies, the accuracy and consistency for detecting systemic inflammatory states remain unclear. This systematic review aimed to evaluate the clinical relevance of wearable-derived HRV indices in relation to established inflammatory biomarkers. Methods: A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted through April 2025. Due to methodological heterogeneity, findings were synthesized using the Synthesis Without Meta-analysis (SWiM) framework with vote counting, effect-direction plots, and sign tests. Results: Eleven studies involving 2419 participants met the inclusion criteria. Vote counting demonstrated that SDNN showed a predominantly inverse association with CRP, with 83% of comparisons indicating reduced SDNN in the presence of elevated CRP (sign test p = 0.031). In contrast, associations between RMSSD and inflammatory cytokines were heterogeneous and largely non-significant. ECG-based wearable devices yielded more consistent associations than photoplethysmography-based devices, while recording duration and population characteristics contributed to variability across studies. Conclusions: Wearable-derived HRV, particularly SDNN from ECG-based devices, shows a consistent inverse association with CRP, supporting its role as a non-invasive physiological correlate of systemic inflammation. However, heterogeneity and the lack of diagnostic accuracy metrics limit conclusions regarding clinical utility. At present, wearable HRV should be considered an exploratory or adjunctive biomarker, pending validation in standardized longitudinal studies with formal diagnostic performance assessment.
- 11 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 538
Open AccessClinical Evidence of Wearable-Derived Heart Rate Variability for Detecting Systemic Inflammation: A Systematic Review
Background/Objectives: Wearable devices capable of capturing heart rate variability (HRV) enable continuous assessment of autonomic nervous system function in real-world settings. Because systemic inflammation disrupts autonomic balance through vagal withdrawal and sympathetic activation, HRV has been proposed as a non-invasive digital biomarker of inflammatory activity. Despite the rapid expansion of wearable sensor technologies, the accuracy and consistency for detecting systemic inflammatory states remain unclear. This systematic review aimed to evaluate the clinical relevance of wearable-derived HRV indices in relation to established inflammatory biomarkers. Methods: A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted through April 2025. Due to methodological heterogeneity, findings were synthesized using the Synthesis Without Meta-analysis (SWiM) framework with vote counting, effect-direction plots, and sign tests. Results: Eleven studies involving 2419 participants met the inclusion criteria. Vote counting demonstrated that SDNN showed a predominantly inverse association with CRP, with 83% of comparisons indicating reduced SDNN in the presence of elevated CRP (sign test p = 0.031). In contrast, associations between RMSSD and inflammatory cytokines were heterogeneous and largely non-significant. ECG-based wearable devices yielded more consistent associations than photoplethysmography-based devices, while recording duration and population characteristics contributed to variability across studies. Conclusions: Wearable-derived HRV, particularly SDNN from ECG-based devices, shows a consistent inverse association with CRP, supporting its role as a non-invasive physiological correlate of systemic inflammation. However, heterogeneity and the lack of diagnostic accuracy metrics limit conclusions regarding clinical utility. At present, wearable HRV should be considered an exploratory or adjunctive biomarker, pending validation in standardized longitudinal studies with formal diagnostic performance assessment.
- Open Access
- 4 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluating the Clinical Accuracy of Wearable HRV Devices in Inflammation Monitoring: A Systematic Review (Preprint)
BACKGROUND Systemic inflammation is a key contributor to many chronic and acute diseases, yet its monitoring often requires invasive procedures. Heart rate variability (HRV), a non-invasive marker of autonomic nervous system function, has shown potential as a surrogate indicator of inflammation. With wearable devices now capable of continuous HRV monitoring, their clinical validity for inflammation detection requires systematic evaluation. OBJECTIVE This systematic review aims to evaluate the clinical accuracy of wearable devices in monitoring systemic inflammation by examining the association between heart rate variability (HRV) indices specifically SDNN and RMSSD and inflammatory biomarkers such as C-reactive protein (CRP), interleukins, and TNF-α across diverse inflammatory conditions. The goal is to assess the consistency and direction of associations and to explore the potential of wearable HRV monitoring as a non-invasive tool for inflammation detection. METHODS A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted (April 2025). Studies were eligible if they compared wearable-derived HRV parameters to inflammatory biomarkers (CRP, IL-6, IL-10, TNF-α). Risk of bias was assessed using QUADAS-2. Synthesis followed the SWiM guideline, employing vote counting and effect direction plots. RESULTS Eleven studies (n = 2,419) were included. Most studies found an inverse association between SDNN and CRP (83%; p = 0.031), while associations with cytokines (IL-6, IL-10, TNF-α) were inconsistent. RMSSD showed mixed results. Device type, recording duration, and population characteristics contributed to heterogeneity. CONCLUSIONS Wearable-derived HRV, especially SDNN, shows promise as a non-invasive marker of systemic inflammation, particularly for CRP. However, further research is needed to establish clinical utility and standardize measurement protocols. CLINICALTRIAL PROSPERO registration number CRD420251029821
- 4 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluating the Clinical Accuracy of Wearable HRV Devices in Inflammation Monitoring: A Systematic Review (Preprint)
BACKGROUND Systemic inflammation is a key contributor to many chronic and acute diseases, yet its monitoring often requires invasive procedures. Heart rate variability (HRV), a non-invasive marker of autonomic nervous system function, has shown potential as a surrogate indicator of inflammation. With wearable devices now capable of continuous HRV monitoring, their clinical validity for inflammation detection requires systematic evaluation. OBJECTIVE This systematic review aims to evaluate the clinical accuracy of wearable devices in monitoring systemic inflammation by examining the association between heart rate variability (HRV) indices specifically SDNN and RMSSD and inflammatory biomarkers such as C-reactive protein (CRP), interleukins, and TNF-α across diverse inflammatory conditions. The goal is to assess the consistency and direction of associations and to explore the potential of wearable HRV monitoring as a non-invasive tool for inflammation detection. METHODS A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted (April 2025). Studies were eligible if they compared wearable-derived HRV parameters to inflammatory biomarkers (CRP, IL-6, IL-10, TNF-α). Risk of bias was assessed using QUADAS-2. Synthesis followed the SWiM guideline, employing vote counting and effect direction plots. RESULTS Eleven studies (n = 2,419) were included. Most studies found an inverse association between SDNN and CRP (83%; p = 0.031), while associations with cytokines (IL-6, IL-10, TNF-α) were inconsistent. RMSSD showed mixed results. Device type, recording duration, and population characteristics contributed to heterogeneity. CONCLUSIONS Wearable-derived HRV, especially SDNN, shows promise as a non-invasive marker of systemic inflammation, particularly for CRP. However, further research is needed to establish clinical utility and standardize measurement protocols. CLINICALTRIAL PROSPERO registration number CRD420251029821
- Open Access
- 27 October 2023
- Published by Universitas Negeri Yogyakarta in MEDIKORA
- Vol. 22 (2) , 1-9
PREVALENCE OF GESTATIONAL DIABETES MELLITUS IN THE SPECIAL REGION OF YOGYAKARTA
Gestational Diabetes Mellitus (GDM) is glucose intolerance when first detected during pregnancy. The prevalence of DMG in the last 20 years has significantly increased. The high prevalence of GDM has implications for maternal and child health. Mother has gestational hypertension and preeclampsia. Babies born are at risk for macrosomia, shoulder dystocia, and neonatal hypoglycemia. This study aims to see the prevalence of DMG in the Special Region of Yogyakarta. This study is an analytic observational study with a cross-sectional design. The study population was pregnant women with a gestational age of 24-28 weeks who checked themselves at the puskesmas in Yogyakarta. The research time is September 2018 to March 2019. The data analysis used is the Chi Square test. This prevalence study was conducted using the criteria of the World Health Organization (WHO), IADPSG/American Diabetes Association (ADA), NICE and Diabetes in Preganancy in India (DIPSI). The highest prevalence of DMG in the study was found in the NICE diagnostic criteria with a value of 14.9% then the DIPSI criteria 12.6%, IADPSG 12.1% and WHO 11.7%.
- 27 October 2023
- Published by Universitas Negeri Yogyakarta in MEDIKORA
- Vol. 22 (2) , 1-9
Open AccessPREVALENCE OF GESTATIONAL DIABETES MELLITUS IN THE SPECIAL REGION OF YOGYAKARTA
Gestational Diabetes Mellitus (GDM) is glucose intolerance when first detected during pregnancy. The prevalence of DMG in the last 20 years has significantly increased. The high prevalence of GDM has implications for maternal and child health. Mother has gestational hypertension and preeclampsia. Babies born are at risk for macrosomia, shoulder dystocia, and neonatal hypoglycemia. This study aims to see the prevalence of DMG in the Special Region of Yogyakarta. This study is an analytic observational study with a cross-sectional design. The study population was pregnant women with a gestational age of 24-28 weeks who checked themselves at the puskesmas in Yogyakarta. The research time is September 2018 to March 2019. The data analysis used is the Chi Square test. This prevalence study was conducted using the criteria of the World Health Organization (WHO), IADPSG/American Diabetes Association (ADA), NICE and Diabetes in Preganancy in India (DIPSI). The highest prevalence of DMG in the study was found in the NICE diagnostic criteria with a value of 14.9% then the DIPSI criteria 12.6%, IADPSG 12.1% and WHO 11.7%.